Neurocrine reports sustained benefits of INGREZZA for Huntington's chorea
PositiveFinancial Markets

Neurocrine has announced promising results regarding its drug INGREZZA, showing sustained benefits for patients suffering from Huntington's chorea. This is significant as it highlights the potential for improved quality of life for those affected by this challenging neurodegenerative disorder, offering hope for better management of symptoms.
— Curated by the World Pulse Now AI Editorial System